Latest 20-F annual reports

NASDAQ
Nanobiotix S.A. files its 20-F annual report, detailing financial results for the year ended December 31, 2024, and highlighting its strategic partnership with Janssen and ongoing clinical trials.
NASDAQ
Galmed Pharmaceuticals reports its fiscal year 2024 results, highlighting a strategic shift towards oncology and cardiometabolic indications while managing operating losses.
NYSE
GeoPark's 20-F filing highlights its strategic focus on profitable growth and sustainable development across Latin America, with a production target of 100 mboepd by 2030.
NYSE
Kenon Holdings Ltd. files its annual report on Form 20-F, disclosing a change in its principal accountant from KPMG LLP to Somekh Chaikin.
AMEX
Latam Logistic Properties' 20-F filing reveals financial details for the year ended December 31, 2024, highlighting revenue, expenses, and future outlook.
NASDAQ
Cognyte Software Ltd. files its annual report for the fiscal year ended January 31, 2025, and amends its share incentive plan to increase available shares.
NASDAQ
Himax Technologies files its 20-F report, detailing financial performance and key business activities for the year ended December 31, 2024.
NASDAQ
Swvl Holdings Corp releases its 20-F filing, detailing financial performance for the year ended December 31, 2024, including a restatement of prior-year financials and strategic shifts towards profitability.
NASDAQ
POET Technologies reports a significant increase in net loss for 2024, driven by R&D investments and non-cash adjustments, while strategically focusing on its Optical Interposer technology.
NASDAQ
Hesai Group releases its annual report on Form 20-F, providing insights into its lidar technology, business strategy, and financial results for the year ended December 31, 2024.
NASDAQ
International General Insurance Holdings Ltd. files its annual report on Form 20-F, detailing its financial performance for the fiscal year ended December 31, 2024.
SatixFy Communications Ltd. amends its Master Purchase Agreement with MDA Space, increasing the pre-purchase amount and outlining milestone-based payments, while also addressing financial uncertainties and ongoing legal proceedings.
NYSE
Tenaris consolidated its industry position in 2024, delivering solid financial results and completing strategic investments, despite a fatal accident and challenges in Mexico.
NASDAQ
Evaxion Biotech A/S releases its 20-F filing, outlining its financial results for the year ended December 31, 2024, and highlighting key operational and strategic updates.
NYSE
Aegon Ltd. files an amendment to its 2024 annual report to include audited financial statements of ASR Nederland N.V., a significant subsidiary.
NYSE
LightInTheBox Holdings navigates a challenging year with a strategic focus on brand-centric apparel design, reporting its 20-F filing for the fiscal year ended December 31, 2024.
AMEX
Fury Gold Mines' 20-F filing details the company's financial results for FY2024, strategic acquisition of the lonore South project, and ongoing exploration activities.
NYSE
TIMB
Tim SA
TIM S.A. has filed an amendment to its annual report on Form 20-F for the year ended December 31, 2024, solely to include hyperlinks to exhibits.
Sendas Distribuidora S.A. releases its 20-F filing, outlining financial results, strategic initiatives, and future outlook for the Brazilian retailer.
Embraer's latest 20-F filing highlights financial performance, strategic initiatives, and key risk factors impacting the company's global operations.
NYSE
TIMB
Tim SA
TIM S.A.'s 20-F filing reveals a year of growth driven by mobile services and strategic partnerships, alongside a commitment to efficiency and shareholder returns.
NYSE
Brookfield Business Corporation releases its annual report on Form 20-F, detailing its financial performance and operational activities for the fiscal year ended December 31, 2024.
Mainz Biomed N.V. announces its annual results for the fiscal year ended December 31, 2024, highlighting a strategic shift towards European market expansion and preparations for U.S. market entry.
Femto Technologies Inc. reports a net loss of $47.59 million for the year ended December 31, 2024, amid ongoing war in Israel and strategic shifts in its cannabis business.
NASDAQ
Rail Vision Ltd.'s 20-F filing details its remuneration policy for company officers and provides an overview of its business strategy in the railway safety and data market.
NYSE
Okeanis Eco Tankers Corp. releases its 20-F filing, summarizing the company's financial performance and operational activities for the year ended December 31, 2024.
NYSE
SharkNinja's 20-F filing highlights a year of significant growth, driven by innovative products and strategic global expansion, despite identifying material weaknesses in internal controls.
NASDAQ
Quantum BioPharma files an amendment to its 20-F annual report to include an audit report from MNP LLP and an index to the financial statements.
NASDAQ
A2Z Cust2Mate Solutions Corp. reports its 20-F filing, detailing financial results and operational updates for the fiscal year ended December 31, 2024.
NASDAQ
Lucas GC Limited's Form 20-F details the company's financial performance for the year ended December 31, 2024, highlighting revenue shifts and strategic adjustments.